1. A Multicenter Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Elderly Patients With Advanced Pancreatic Cancer. Issue 2 (February 2020) Authors: Kobayashi, Satoshi; Ueno, Makoto; Ikeda, Masafumi; Ozaka, Masato; Sano, Yusuke; Hirotani, Akane; Tozuka, Yuichiro; Fukushima, Taito; Tezuka, Shun; Moriya, Satoshi; Umemoto, Kumiko; Watanabe, Kazuo; Sasaki, Mitsuhito; Hashimoto, Yusuke; Imaoka, Hiroshi; Ohno, Izumi; Mitsunaga, Shuichi; Yamada, Iku... Journal: Pancreas Issue: Volume 49:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A novel laser‐cut fully covered metal stent with anti‐reflux valve in patients with malignant distal biliary obstruction refractory to conventional covered metal stent. (26th April 2021) Authors: Yamada, Yuto; Sasaki, Takashi; Takeda, Tsuyoshi; Mie, Takafumi; Furukawa, Takaaki; Kasuga, Akiyoshi; Matsuyama, Masato; Ozaka, Masato; Igarashi, Yoshinori; Sasahira, Naoki Journal: Journal of hepato-biliary-pancreatic sciences Issue: Volume 28:Number 7(2021) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407). (March 2023) Authors: Ozaka, Masato; Nakachi, Kohei; Kobayashi, Satoshi; Ohba, Akihiro; Imaoka, Hiroshi; Terashima, Takeshi; Ishii, Hiroshi; Mizusawa, Junki; Katayama, Hiroshi; Kataoka, Tomoko; Okusaka, Takuji; Ikeda, Masafumi; Sasahira, Naoki; Miwa, Haruo; Mizukoshi, Eishiro; Okano, Naohiro; Mizuno, Nobumasa; Yamamot... Journal: European journal of cancer Issue: Volume 181(2023) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized, double‐blind, phase II study of oral histone deacetylase inhibitor resminostat plus S‐1 versus placebo plus S‐1 in biliary tract cancers previously treated with gemcitabine plus platinum‐based chemotherapy. (26th February 2021) Authors: Ueno, Makoto; Morizane, Chigusa; Furukawa, Masayuki; Sakai, Daisuke; Komatsu, Yoshito; Nakai, Yousuke; Tsuda, Masahiro; Ozaka, Masato; Mizuno, Nobumasa; Muto, Manabu; Fukutomi, Akira; Ikeda, Masafumi; Tsuji, Akihito; Katanuma, Akio; Moriwaki, Toshikazu; Kajiwara, Takeshi; Ishii, Hiroshi; Negoro, ... Journal: Cancer medicine Issue: Volume 10:Number 6(2021) Page Start: 2088 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Analysis of prognostic factors for borderline resectable pancreatic cancer after neoadjuvant chemotherapy: the importance of CA19-9 decrease in patients with elevated pre-chemotherapy CA19-9 levels. Issue 1 (January 2023) Authors: Ono, Yoshihiro; Inoue, Yosuke; Ito, Hiromichi; Sasaki, Takashi; Takeda, Tsuyoshi; Ozaka, Masato; Sasahira, Naoki; Hiratsuka, Makiko; Matsueda, Kiyoshi; Oba, Atsushi; Sato, Takafumi; Saiura, Akio; Takahashi, Yu Journal: HPB Issue: Volume 25:Issue 1(2023) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. (12th December 2020) Authors: Yamamoto, Masakazu; Yoshida, Masahiro; Furuse, Junji; Sano, Keiji; Ohtsuka, Masayuki; Yamashita, Shingo; Beppu, Toru; Iwashita, Yukio; Wada, Keita; Nakajima, Takako Eguchi; Sakamoto, Katsunori; Hayano, Koichi; Mori, Yasuhisa; Asai, Koji; Matsuyama, Ryusei; Hirashita, Teijiro; Hibi, Taizo; Sakai, ... Journal: Journal of hepato-biliary-pancreatic sciences Issue: Volume 28:Number 1(2021) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comparison of Treatment Outcomes Between Gemcitabine With Nab-Paclitaxel and Modified FOLFIRINOX for First-Line Chemotherapy in Metastatic and Recurrent Pancreatic Cancer: Propensity Score Matching. Issue 4 (April 2021) Authors: Mie, Takafumi; Sasaki, Takashi; Takeda, Tsuyoshi; Fukuda, Koshiro; Furukawa, Takaaki; Yamada, Yuto; Kasuga, Akiyoshi; Matsuyama, Masato; Ozaka, Masato; Sasahira, Naoki Journal: Pancreas Issue: Volume 50:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Diagnostic Yield of Serial Pancreatic Juice Aspiration Cytologic Examination With Brush Cytology for Pancreatic Ductal Stenosis. Issue 8 (September 2022) Authors: Mie, Takafumi; Sasaki, Takashi; Takeda, Tsuyoshi; Okamoto, Takeshi; Mori, Chinatsu; Furukawa, Takaaki; Yamada, Yuto; Kasuga, Akiyoshi; Matsuyama, Masato; Ozaka, Masato; Sasahira, Naoki Journal: Pancreas Issue: Volume 51:Issue 8(2022) Page Start: 995 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?. Issue 1 (December 2015) Authors: Osumi, Hiroki; Shinozaki, Eiji; Suenaga, Mitsukuni; Kumekawa, Yosuke; Ogura, Mariko; Ozaka, Masato; Matsusaka, Satoshi; Chin, Keisho; Yamamoto, Noriko; Mizunuma, Nobuyuki Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial. (November 2019) Authors: Doi, Toshihiko; Kurokawa, Yukinori; Sawaki, Akira; Komatsu, Yoshito; Ozaka, Masato; Takahashi, Tsuyoshi; Naito, Yoichi; Ohkubo, Shuichi; Nishida, Toshirou Journal: European journal of cancer Issue: Volume 121(2019) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗